Sicart Associates LLC Ionis Pharmaceuticals Inc Transaction History
Sicart Associates LLC
- $279 Million
- Q1 2025
A detailed history of Sicart Associates LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sicart Associates LLC holds 185,646 shares of IONS stock, worth $5.53 Million. This represents 2.01% of its overall portfolio holdings.
Number of Shares
185,646
Previous 185,821
0.09%
Holding current value
$5.53 Million
Previous $6.5 Million
13.79%
% of portfolio
2.01%
Previous 2.41%
Shares
30 transactions
Others Institutions Holding IONS
# of Institutions
405Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$491 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$422 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$342 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$308 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$235 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.23B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...